These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis. Bregni M; Borrello MG; Siena S; Orazi A; Biassoni D; Bonadonna G; Gianni AM Haematologica; 1989; 74(4):397-400. PubMed ID: 2507414 [TBL] [Abstract][Full Text] [Related]
4. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease. Chan DW; Liang R; Kwong YL; Chan V Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia. Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384 [TBL] [Abstract][Full Text] [Related]
6. Pattern of T-cell receptor delta gene rearrangement by Southern blotting and polymerase chain reaction technique in Hong Kong Chinese patients with non-T-cell hematological malignancies. Chan DW; Liang R; Kwong YL Hematol Oncol; 1996 Jun; 14(2):57-66. PubMed ID: 8876635 [TBL] [Abstract][Full Text] [Related]
7. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods. Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307 [TBL] [Abstract][Full Text] [Related]
8. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders]. Griesser DH Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates. Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629 [TBL] [Abstract][Full Text] [Related]
11. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Hardingham JE; Kotasek D; Sage RE; Dobrovic A; Gooley T; Dale BM Bone Marrow Transplant; 1993 Jan; 11(1):15-20. PubMed ID: 8381694 [TBL] [Abstract][Full Text] [Related]
12. Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients. Nadkarni JJ; Jhaver KG; De AK; Soman CS; Nadkarni KS Neoplasma; 1993; 40(1):15-20. PubMed ID: 8350943 [TBL] [Abstract][Full Text] [Related]
13. [Incidence of lymphoma cells in the bone marrow and peripheral blood in patients with non-Hodgkin's type lymphoma]. Rajić M; Vidaković B; Bojić P Srp Arh Celok Lek; 1989; 117(1-2):27-37. PubMed ID: 2799547 [TBL] [Abstract][Full Text] [Related]
14. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis. Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides. Bakels V; Van Oostveen JW; Geerts ML; Gordijn RL; Walboomers JM; Scheffer E; Meijer CJ; Willemze R J Pathol; 1993 Jul; 170(3):249-55. PubMed ID: 8133398 [TBL] [Abstract][Full Text] [Related]
18. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma. Hétu F; Coutlée F; Roy DC Mol Cell Probes; 1994 Dec; 8(6):449-57. PubMed ID: 7700265 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow and peripheral blood changes in non-Hodgkin's lymphoma. Lim EJ; Peh SC Singapore Med J; 2000 Jun; 41(6):279-85. PubMed ID: 11109344 [TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells. Yao M; Fouillard L; Lemoine FM; Bouchet S; Firat H; Andreu G; Gorin NC; Douay L; Lopez M Bone Marrow Transplant; 2000 Sep; 26(5):497-503. PubMed ID: 11019838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]